What is the appropriate weight‑based intravenous dose and administration technique for midazolam in a 10‑year‑old child weighing approximately 30–40 kg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

IV Midazolam Administration for a 10-Year-Old Child (30-40 kg)

For sedation/anxiolysis in a 10-year-old child, administer midazolam 0.025-0.05 mg/kg IV over 2-3 minutes, with a maximum single dose of 5 mg, and wait an additional 2-3 minutes between doses to assess effect before redosing. 1

Weight-Based Dosing Algorithm

Initial Dose

  • Start with 0.025-0.05 mg/kg IV (for a 30-40 kg child, this equals approximately 0.75-2 mg) 1
  • Administer slowly over 2-3 minutes to minimize risk of respiratory depression 1, 2
  • Maximum single dose: 5 mg regardless of weight 1

Titration Protocol

  • Wait 3-5 minutes after initial dose for peak CNS effect before considering additional dosing 1
  • Total cumulative dose may reach up to 0.4 mg/kg (12-16 mg for a 30-40 kg child), but typically does not exceed 10 mg 1, 2
  • Redose in small increments (0.025 mg/kg) every 3-5 minutes until desired sedation achieved 1

Administration Technique

Preparation

  • Use 1 mg/mL formulation to facilitate slower, more controlled injection 2
  • May dilute with 0.9% sodium chloride or 5% dextrose if needed 2
  • Ensure IV access is secure to avoid extravasation 2

Injection Method

  • Inject slowly over at least 2-3 minutes - this is critical to prevent oversedation and respiratory depression 1, 2
  • Observe continuously during administration for signs of respiratory compromise 1
  • Do NOT administer as rapid IV push 2

Context-Specific Dosing

For Rapid Sequence Intubation

  • Higher dose: 0.2 mg/kg IV (6-8 mg for 30-40 kg child) 1
  • Allow 2-3 minutes for effect before administering neuromuscular blocking agent 1
  • Lower doses are ineffective for RSI 1

For Refractory Status Epilepticus

  • Loading dose: 0.15-0.20 mg/kg IV 1
  • Followed by continuous infusion if needed 1

Critical Safety Monitoring

Mandatory Monitoring

  • Continuous pulse oximetry throughout procedure 1, 2
  • Respiratory rate and effort - most common serious complication is respiratory compromise 1
  • Cardiac monitoring in high-risk patients 1
  • Have flumazenil immediately available (0.01 mg/kg) for reversal of life-threatening respiratory depression 1

High-Risk Considerations

  • Reduce dose if opioids co-administered - increased risk of apnea when combined with other sedatives 1, 2
  • Prepare for respiratory support - bag-valve-mask and appropriate airway equipment must be immediately available 1, 2
  • Younger children (<6 years) may require higher mg/kg doses but this 10-year-old falls in the 6-12 year age bracket 1

Common Pitfalls to Avoid

Dosing Errors

  • Do NOT skip the waiting period between doses - peak EEG effect takes approximately 3-5 minutes, and premature redosing leads to cumulative oversedation 1, 2
  • Do NOT use adult dosing - children 6-12 years require specific weight-based calculations 1
  • Do NOT exceed 10 mg total dose in most procedural sedation scenarios 1

Administration Errors

  • Avoid rapid injection - increases risk of respiratory depression and hypotension 2
  • Do NOT give IM when IV access available - IM route has unpredictable absorption and is not preferred for controlled sedation 1

Monitoring Failures

  • Paradoxical agitation may occur especially in younger children - be prepared to manage this reaction 1
  • Prolonged sedation occurs with higher cumulative doses - extended observation required 1
  • Hypotension can occur particularly if administered too rapidly or in hemodynamically compromised patients 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.